Skip to content

Testing a home sleep monitoring system for sleep apnoea

Evaluating an ambulatory monitoring system in obstructive sleep apnoea: a proof-of-concept study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN17418746
Enrollment
10
Registered
2025-11-06
Start date
2025-11-13
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnoea Nervous System Diseases

Interventions

This is a single-centre, prospective, non-randomized pilot study designed to assess the feasibility of using a novel ambulatory monitoring system (AMS) to detect respiratory disturbances in people wit

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Willing and able to give informed consent for participation in the study 2. Aged 18 years or above 3. Referred with required suspected obstructive sleep apnoea

Exclusion criteria

Exclusion criteria: Allergy or intolerance to hydrocolloid adhesive used for AMS chest patch attachment

Design outcomes

Primary

MeasureTime frame
The feasibility of using an Ambulatory Monitoring System (AMS) which consists of a chest patch and pulse oximeter to detect overnight >3 % desaturations compared to clinical standard respiratory polygraphy (RP). This will be assessed on night 1 of the study.

Secondary

MeasureTime frame
1. The feasibility of using an AMS (chest patch and pulse oximeter) to detect apnoeas and hypopnoeas compared to clinical standard RP, assessed on night 1 of the study. 2. The feasibility and patient experience of using an AMS, assessed on day 5-7 of the study, at the final study visit. Exploratory objectives: 1. Sleep metrics (apnoea-hypopnoea index, oxygen desaturations index and burden) of AMS and RP assessed on night 1 of the study. 2. Night-to-night variability of sleep apnoea severity measured by AMS on nights 1-5 of the study (all nights up to the final study visit, visit 3)

Countries

England, United Kingdom

Contacts

Public ContactChris Turnbull
christopher.turnbull@ouh.nhs.uk+44 (0)1865225789

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026